Indication

Recurrent Laryngeal Carcinoma

1 clinical trial

1 drug

Clinical trial

RESILIENCE: Effect of Comprehensive Celecoxib Through Treatment for Advanced-Stage Head and Neck Cancer: A Randomized, Double-Blinded, Placebo-Controlled Trial

Status: , Estimated PCD: 2024-10-12

Drug